Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA Peptide Reclassification 2026: What It Means for Providers The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype